Non-executive directors are appointed by the Trust's Council of Governors on a four year fixed-term contract. They are either residents of the local community, or King's patients. They bring a wide range of skill and experience to the organisation.
Collectively, they provide strategic guidance, support and challenge to the Trust to ensure it meets its objectives.
Lord Kerslake - Chair
Graduating with a first class degree in Mathematics from Warwick University, Lord Kerslake trained as an accountant and worked at the Greater London Council, the Inner London Educational Authority and the London Borough of Hounslow in finance roles before becoming Chief Executive of the London Borough of Hounslow in 1990. In 1997 he moved to take over as Chief Executive of Sheffield City Council – the fourth largest local authority in the UK.
From 2008 to 2010 Lord Kerslake was Chief Executive of the Homes and Communities Agency. He served as Permanent Secretary of the Department for Communities and Local Government from 2010 to February 2015 and was also Head of the Civil Service from January 2012 until September 2014.
He was created a life peer in March 2015 and became Chair of King’s on 1 April 2015.
Chris Stooke graduated in economics from Durham University and started his accountancy career at PwC; he was made partner in 1990 and was responsible for the audit of a number of blue chip companies in the UK and Europe, mainly in the financial services sector. From 2003 to 2009 he was Chief Financial Officer of Catlin Group, the FTSE 350 insurer. He is now a non-executive director at three companies and one charity, in addition to King's. He has lived in South London almost all his life and is now based in Dulwich, married with four children.
Dr Alix Pryde
Dr Pryde graduated in Physics from University College London then completed a PhD in Theoretical Physics at the University of Cambridge. She joined McKinsey & Co as a strategy consultant before being hired by the BBC where she enjoyed a range of roles, including Head of Strategy for BBC Radio then BBC News, running the COO’s office and ultimately leading the BBC’s Distribution team, playing a central role in the delivery of TV Digital Switchover and the BBC’s groundbreaking coverage of London 2012. Alix was subsequently recruited by Vodafone UK to lead Consumer Innovation.
In 2016, she joined Sky where she is Director of Service Strategy & Operational Delivery, driving transformation within Customer Services.
Alix was born and raised in Bromley and moved to Camberwell in 2000 where she now lives with her husband and two children, who were born under the care of King’s. Alix joined the King’s Board in November 2015.
Erik Nordkamp has been Managing Director for Pfizer Ltd since February 2015, having worked at the company in other senior roles since 2010. These roles include President and Managing Director, Greece, Cyprus and Malta (2012-15) and Regional Strategy Lead (2010-12).
Prior to this, Mr Nordkamp worked at Eli Lilly and Company as European Senior Director of Transformation and Lean Six Sigma. He has an MSc in Biomedical Sciences from Radboud University, Nijmegen (1992) and an MBA from the Erasmus University Rotterdam (1999).
He is originally from Holland but lives and works in the UK. He is married with two children.
Faith Boardman lives in Lambeth, and brings 40 years of public service at both the local and the national levels. She has a proven track record of delivering service improvements in large public sector organisations that are dealing with substantial change, and with financial, performance and customer challenges.
She has been Chief Executive of both the Child Support Agency (1997-2000) and more recently at Lambeth Council (2000-05). She is Chair of Trustees for Vauxhall City Farm and London Ecumenical Aids Trust, and was formerly a non-executive member of the Metropolitan Police Authority. Faith joined the King's Board in March 2012.
Professor Ghulam J Mufti
Professor Mufti has worked at the Trust since 1985 when he was appointed as a senior lecturer/consultant haematologist. His current appointment is Professor of Haemato-oncology,Clinical Director of Pathology and Head of the Department of Haematology, one of the largest in Europe. Ghulam is internationally renowned for research and treatment of myelodysplastic syndromes (MDS) and other pre-leukaemic diseases, and has published over 400 original papers in medical journals.
He is founding member of the International MDS foundation Board, Chair of the UK MDS Forum and Member of GSTS Members Board. He was formerly a member of the scientific committee of Leukaemia & Lymphoma Research. In 2017 he was awarded an OBE for services to haematological medicine. He has been a non-executive director of the Trust since December 2012.
Professor Jonathan Cohen
Professor Cohen completed his medical degree at Charing Cross Hospital Medical School in 1975 and has worked in the NHS in the field of infectious diseases for over 30 years, becoming Chair and Head of Department at Hammersmith Hospital and Imperial College School of Medicine. His research interest is severe bacterial infections and he has an international reputation for his work in helping to develop new forms of treatment for sepsis and septic shock.
He was the founding Dean of Brighton and Sussex Medical School, which has already provided over 700 new doctors to the NHS. He has also served as member or Chair for a wide range of national and international bodies, and spent five years as Editor-in-Chief of the International Journal of Infectious Diseases. He is currently President of the International Society for Infectious Diseases, a trustee of Arthritis Research UK and member of the Scientific Advisory Board of the Lister Institute.
Professor Richard Trembath
Professor Trembath completed his medical degree at Guy’s Hospital Medical School in 1981. He is a Clinician Scientist internationally recognised for sustained contributions to medical science through the development and application of genetics and genomics to an enhanced understanding of the pathogenesis of rare and common human disease. He has championed translational bio-medical research and provides leadership for academia in the UK and beyond. His research interests include the identification and characterisation of genes and the molecular pathways underlying a range of human common and rare disorders.
Currently he is the Executive Dean at the Faculty of Life Sciences and Medicine, King’s College London, and Professor of Medical Genetics. From 2011 to 2015 he was Vice-Principal for Health at Queen Mary University of London and a non-executive director at Barts Health NHS Trust. He was a founding Director of the National Institute for Health Research Comprehensive Biomedical Research Centre in association with Guy's and St Thomas' NHS Foundation Trust. He is a Fellow of the Academy of Medical Sciences and a former Senior Investigator for the National Institute of Health Research. He joined the King's Board in December 2016.
Sue Slipman was the founding Chief Executive of the Foundation Trust Network, the national trades associations for authorised and aspirant foundation trusts in the NHS. She was also Director of the campaigning charity The National Council for One Parent Families, and ran the Gas Consumers Council.
She was an Executive Director at Camelot where she held the role of Director of Corporate Responsibility before becoming Director of Communications. She has been Chair of the Financial Ombudsman Service, has held a number of non-executive positions in public life and is currently a trustee of NEST Corporation, the pension scheme set up by government to support auto-enrolment.